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Melodic Intonation Therapy (MIT) is a language production therapy for severely non-
fluent aphasic patients using melodic intoning and rhythm to restore language. Although
many studies have reported its beneficial effects on language production, randomized
controlled trials (RCT) examining the efficacy of MIT are rare. In an earlier publication,
we presented the results of an RCT on MIT in subacute aphasia and found that MIT
was effective on trained and untrained items. Further, we observed a clear trend in
improved functional language use after MIT: subacute aphasic patients receiving MIT
improved considerably on language tasks measuring connected speech and daily life
verbal communication. Here, we present the results of a pilot RCT on MIT in chronic
aphasia and compare these to the results observed in subacute aphasia. We used a
multicenter waiting-list RCT design. Patients with chronic (>1 year) post-stroke aphasia
were randomly allocated to the experimental group (6 weeks MIT) or to the control
group (6 weeks no intervention followed by 6 weeks MIT). Assessments were done
at baseline (T1), after 6 weeks (T2), and 6 weeks later (T3). Efficacy was evaluated
at T2 using univariable linear regression analyses. Outcome measures were chosen to
examine several levels of therapy success: improvement on trained items, generalization
to untrained items, and generalization to verbal communication. Of 17 included patients,
10 were allocated to the experimental condition and 7 to the control condition. MIT
significantly improved repetition of trained items (β = 13.32, p = 0.02). This effect did
not remain stable at follow-up assessment. In contrast to earlier studies, we found only
a limited and temporary effect of MIT, without generalization to untrained material or to
functional communication. The results further suggest that the effect of MIT in chronic
aphasia is more restricted than its effect in earlier stages post stroke. This is in line with
studies showing larger effects of aphasia therapy in earlier compared to later stages
post stroke. The study was designed as an RCT, but was underpowered. The results
therefore have to be interpreted cautiously and future larger studies are needed.
Clinical Trial Registration: www.ClinicalTrials.gov, identifier NTR 1961.
Keywords: aphasia, stroke rehabilitation, language therapy, melodic intonation therapy, effectiveness
INTRODUCTION
Aphasia is a language disorder resulting from brain damage. It is a heterogeneous phenomenon,
varying from mild word retrieval difficulties to a complete inability to produce and understand
language. A wide variety of language treatments is available with a growing body of evidence
(Robey, 1998; Cicerone et al., 2005; Rohling et al., 2009; Brady et al., 2012; Cotoi et al., 2016).
Frontiers in Human Neuroscience | www.frontiersin.org 1 November 2016 | Volume 10 | Article 533
fnhum-10-00533 October 31, 2016 Time: 18:14 # 2
Van Der Meulen et al. Melodic Intonation Therapy in Chronic Aphasia
Aphasia is often subdivided into fluent and non-fluent aphasia.
Non-fluent aphasia generally results from a stroke in left fronto-
temporal regions and is characterized by slow, effortful speech.
Language production in these patients is mostly restricted to one-
or two-word utterances. Despite their severe language production
impairment, non-fluent aphasic patients are able to sing fluently,
which has led to the use of singing and music in aphasia therapy.
One of the most formalized aphasia treatment methods using
music is Melodic Intonation Therapy (MIT) (Albert et al.,
1973). In MIT, ‘musical’ elements of language, such as rhythm
and intonation, are used to facilitate and improve language
production. Patients repeat short melodically intoned utterances
(Albert et al., 1973; Helm-Estabrooks et al., 1989; Sparks, 2008).
The therapy includes several therapeutic techniques, such as left
hand-tapping and reducing speech rate. Gradually, the speech-
language therapist (SLT) provides less support, until a patient is
able to produce a trained utterance independently. MIT aims to
improve connected speech.
The original American MIT has been translated into several
languages, including French (Zumbansen et al., 2014), Persian
(Bonakdarpour et al., 2003), Dutch (Van der Lugt-van Wiechen
and Verschoor, 1987), and Caucasian (Breier et al., 2010). It is
used by SLTs world-wide and many studies have reported its
beneficial effects on language production (Sparks et al., 1974;
Goldfarb and Bader, 1979; Carlomagno et al., 1997; Wilson
et al., 2006; Schlaug et al., 2008, 2009; Hough, 2010). However,
most of these studies were case studies or case series in chronic
aphasia (Van der Meulen et al., 2012). To our knowledge,
there are three non-randomized group studies on MIT in
chronic aphasia. In two of them, data from a control group
are lacking: Bonakdarpour et al. (2003) examined the effect
of MIT in a group of seven Persian-speaking individuals with
chronic non-fluent aphasia and observed improved performance
on several language tasks as well as in connected speech.
Cortese et al. (2015) reported improved language production
in six chronic Italian aphasic patients after MIT as well as on
follow-up assessments 6 months later. A third, recent group
study was done by Wan et al. (2014). They examined the
effects of MIT in a group of 11 chronic non-fluent English-
speaking aphasic patients and reported improved communicative
effectiveness and verbal fluency after MIT, associated with
structural changes in the white matter underlying the right
inferior frontal gyrus. In the untreated control group (n = 9),
no changes in right hemisphere brain regions and no language
improvement were observed. However, they do not report any
statistical analyses comparing therapy success in the treated
and untreated groups. In 1994, the American Academy of
Neurology classified MIT as a promising therapy with a
poor level of evidence (American Academy of Neurology,
1994). Despite its widespread use, the quality of the evidence
remains poor (Hurkmans et al., 2012; Van der Meulen et al.,
2012).
We performed a randomized controlled trial (RCT) to
evaluate the efficacy of MIT in subacute aphasia. The results of
the trial in subacute aphasia have been published earlier (Van der
Meulen et al., 2014). In summary, in subacute severely non-fluent
aphasic patients MIT yielded improved repetition of trained as
well as untrained utterances. In addition, we found indications
of a generalization toward improved verbal communication in
daily life. Thirdly, treatment intensity and time post stroke were
related to MIT success, but no patient-related determinants were
observed.
In the present study, we used the same study design to evaluate
MIT efficacy in chronic aphasia and examine whether the results
observed in subacute aphasia could be replicated in a chronic
aphasic population.
MATERIALS AND METHODS
Design
The study was a multicenter waiting-list observer-blinded RCT
with patients randomly allocated to either the experimental or
the control group (Figure 1). We used a computer-generated
allocation sequence, placed in consecutively numbered sealed
opaque envelopes. Between T1 and T2, patients assigned to the
experimental group received intensive MIT (6 weeks, 5 h/week).
Patients in the control group received no individual aphasia
treatment. To improve adherence to the program and prevent
drop out, the control group received 6 weeks intensive MIT
(5 h/week) between T2 and T3, i.e., after the waiting period of
6 weeks. The experimental group received no treatment between
T2 and T3 (Figure 1). Efficacy of MIT was evaluated at T2, where
language improvement after MIT was compared to improvement
in the untreated control group.
The study was approved by the Medical Ethics Committee of
Erasmus University Medical Center. All participants or a close
relative gave written informed consent. For obvious reasons,
patients and therapists could not be blinded to treatment
conditions. The researchers assessing and scoring the tests were
blinded for group allocation and test moment.
Participants
Between 2009 and 2011, patients were recruited through the
Dutch National Association of Persons with Aphasia and from
several outpatient aphasia centers in the Netherlands. Inclusion
criteria were: MIT candidate, right-handed before stroke,>1 year
post stroke, age 18–80 years, and native language Dutch. MIT
candidacy was based on earlier studies (Sparks et al., 1974;
Helm-Estabrooks et al., 1989; Sparks, 2008) and defined as: non-
fluent aphasia (<50 words/min) after a unilateral left-hemisphere
stroke, poor language repetition even for single words [Aachen
Aphasia Test (AAT; Graetz et al., 1991), subtest repetition≤100],
poorly articulated speech (AAT spontaneous language subscale
articulation ≤3), and moderate to good auditory language
comprehension (AAT subtest auditory comprehension ≥33;
functional comprehension ≥5). Exclusion criteria were: prior
stroke resulting in aphasia, bilateral lesion, intensive MIT prior
to start of the study, severe hearing deficit, psychiatric history
relevant to language communication.
Intervention
Melodic intonation therapy was given following the American
MIT manual (Helm-Estabrooks et al., 1989; Sparks, 2008). The
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FIGURE 1 | Flow chart.
program consisted of several levels with increasing difficulty. At
the first level target utterances were short, formulaic phrases
(e.g., ‘How are you?’). As the therapy proceeded, the trained
utterances became more complex and less frequent in daily life
(e.g., ‘a thunderstorm is coming our way’). For each utterance,
a melodically intoned pattern was developed, based on the
natural prosody of the utterance [see Sparks et al., 1974; Sparks,
2008, and the American manual (Helm-Estabrooks et al., 1989)
for more details on the procedure of creating melodically
intoned patterns]. Utterances were trained in a hierarchy of
steps: patients and SLTs first produced the melodically intoned
utterance together, while hand tapping the rhythm of the
utterance. Gradually, the SLT provided less support and the
intoned pattern was replaced by the normal prosody. The final
step consisted of independent spoken production of the target
utterance.
The therapy was given by experienced SLTs in nine
rehabilitation centers and aphasia centers. All were trained to
deliver MIT according to the study protocol (Van der Meulen
et al., 2014). The protocol comprised a list of Dutch target
utterances for each level, along with their intoned pattern. In
addition to this standard set, the SLT and the patient or a close
relative developed a set of personally relevant utterances, such as
utterances related to hobbies or favorite food. At least 50% of the
therapy time had to be spent on training the standard set.
To ensure a treatment intensity of 5 h/week, we developed an
iPod application enabling patients to practice independently at
home. The minimum amount of face-to-face therapy time was
3 h/week. When the SLT was unable to offer 5 hours of treatment
per week, patients used the iPod to practice at home, at least
2 h/week, but no more than 7 h/week. Patients or a close relative
recorded the time spent on homework assignments and SLTs
recorded therapy time for each session.
In the control condition, no individual treatment was offered.
Many of the patients were recruited from aphasia centers, where
they participated in aphasia groups, offering opportunities for
social interaction, as well as low intensity group therapy to
support verbal and non-verbal communication (e.g., written
communication, discussing news items). Participation in these
groups was allowed in both conditions.
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Outcome Measures
Assessment was done at baseline (T1), 6 weeks later (T2),
and 12 weeks later (T3) (Figure 1). Outcome measures were:
the MIT repetition task, the subtests naming, repetition and
auditory comprehension from the AAT (Graetz et al., 1991),
the Amsterdam-Nijmegen Everyday Language Test (ANELT;
Blomert et al., 1995), and the Sabadel story retell task (Van
Eeckhout, 1982). The MIT repetition task was designed for our
two MIT trials and comprised 11 trained and 11 untrained
matched sentences.
When evaluating the effect of aphasia treatment, it is crucial
to distinguish between improvement on trained items (direct
effect), improvement on non-trained items (indirect effect),
and generalization to functional language use (Van der Meulen
et al., 2012; Zumbansen et al., 2014). In this study, we
selected outcome measures to evaluate the effect of MIT at
different levels: (1) improvement in repeating trained items (MIT
repetition task, trained items), (2) generalization to untrained
items (MIT repetition task, untrained items and AAT subtest
repetition), (3) generalization to word retrieval (AAT subtest
naming), (4) further generalization to verbal communication
(ANELT and Sabadel). The goal of MIT is to improve verbal
fluency and connected speech, i.e., the latter level of success.
In addition to these measures for language production, we also
included a language comprehension task (AAT subtest auditory
comprehension) because several studies have reported improved
auditory comprehension after MIT (Sparks et al., 1974; Helm-
Estabrooks, 1983; Bonakdarpour et al., 2003).
Statistical Analysis
Since no data from chronic aphasic patients were available,
we performed an a priori power analysis based on Sabadel
(Van Eeckhout, 1982) data from subacute severe non-fluent
patients participating in a small pilot study (Paul and Pijnenburg,
2002, unpublished). For this small subacute sample, the effect
size was 0.90, considered to be large in terms of Cohen’s
d. With an α = 0.05, β = 0.20 and power = 0.80, the
estimated sample size for this effect size was 15 patients per
group.
Because the data were not normally distributed, we used non-
parametric tests. Potential differences at baseline between the
experimental and the control group were analyzed using Mann–
Whitney U tests for continuous data and Fisher’s Exact Test for
categorical variables.
The efficacy of MIT was evaluated for each outcome measure
at T2 by means of univariable regression analyses, adjusted for
baseline (T1), with group assignment (experimental vs. control)
as the independent variable. Because there was heterogeneity
in both groups with regard to the severity of the aphasia, all
regression analyses were also adjusted for aphasia severity, as
expressed by the score on the AAT Token Test.
We further examined whether, as a group, patients showed
language improvement after MIT. For this, we used the Wilcoxon
signed rank test to examine change from pre-MIT scores (T1
experimental group, T2 control group) to post-MIT scores (T2
experimental group, T3 control group) in all patients.
We considered the following potential determinants for
MIT success: age, gender, aphasia severity (Token Test AAT),
treatment intensity, patients’ linguistic profile at the start of MIT:
pre-MIT scores on AAT language repetition, naming, auditory
comprehension, and the non-verbal Semantic Association Task
(Visch-Brink et al., 2005). The influence of these variables on all
outcome measures was examined through univariable regression
analyses. For these analyses, we used the post-MIT scores of
all patients (T2 experimental group, T3 control group) as the
dependent variable, adjusted for the pre-MIT scores of all patients
(T1 experimental group, T2 control group). Subsequently, scores
on all outcome measures were dichotomized into responders
(improvement >10 on MIT repetition, >14 on AAT repetition,
>16 on AAT naming,>7 on the ANELT,>0 on the Sabadel) and
non-responders (Van der Meulen et al., 2014). Mann–Whitney
U tests and Fisher’s Exact Tests were used to examine group
differences.
All analyses were performed on an intention-to-treat basis
using SPSS version 21. A level of significance of p< 0.05 was used
in all analyses.
RESULTS
Participants
Figure 1 presents the flow chart of patient inclusion. Of the 44
chronic aphasic patients referred to the study, 17 (38.6%) were
included. The main reason for exclusion was failure to meet the
inclusion criteria (n = 20). Other reasons were: unwillingness
to participate because of the treatment intensity (n = 3), travel
distance to a center participating in the trial (n = 3), or other
(n = 1). Ten participants were allocated to the experimental
group that received MIT first and 7 to the control group receiving
MIT after a waiting period of 6 weeks. We were unable to achieve
the aim of 15 patients per group. Inclusion took considerably
longer than anticipated and, after extending the inclusion period
once, no further funding was available. There were no drop-outs
in the experimental group. In the control group there was one
drop-out after the assessment at T2. This patient did not start
MIT for personal reasons.
Table 1 presents the baseline characteristics of both groups.
There were no significant differences between groups.
Efficacy
Table 2 shows the improvements during the intervention period
(T1–T2) for each intervention group, as well as the results of the
between-groups analyses.
After MIT, the experimental group showed significant
improvement on the repetition of both trained and untrained
utterances (Table 2). No significant improvement was observed
on any of the other outcome measures. Unexpectedly, the control
group improved on the AAT repetition task (Table 2). This
observation is difficult to explain, since this group did not receive
any language production treatment.
The regression analysis revealed a positive treatment effect
on trained items: the experimental group improved significantly
more on trained items than the control group (Table 2). On
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TABLE 1 | Baseline characteristics (n = 17).
Experimental Control p
(n = 10) (n = 7)
Mean (SD) Mean (SD)
Age, years 58.1 (15.2) 63.6 (12.7) 0.67
Gender, % male 70% 57.1% 0.64
Educationa 4.8 (2.9) 4.3 (2.6) 0.50
Time post stroke, months 33.1 (19.4) 42.6 (23.7) 0.54
Stroke type
Ischemic, % 80% 100%
Unknown, % 20% 0%
Stroke localization, % LH 100%b 100% 1.0
Handedness, % right handedc 90% 100% 1.0
AAT Token Test 35.4 (10.9) 31.0 (18.7) 1.0
AAT language repetition 53.6 (28.5) 35.3 (22.7) 0.23
AAT auditory comprehension 40.7 (6.4) 41.7 (7.6) 0.89
AAT naming 25.7 (27.8) 16.0 (30.8) 0.30
ANELT 15.7 (6.2) 12.9 (7.1) 0.32
Sabadel, CIUs 4.9 (8.9) 3.3 (8.3) 0.48
MIT repetition 30.7 (26.0) 23.0 (16.8) 0.60
SAT non-verbal 22.9 (5.3) 23.9 (4.8) 0.74
SD, standard deviation; LH, left hemisphere; AAT, Aachen Aphasia Test; ANELT,
Amsterdam-Nijmegen Everyday Language Test; CIU, Correct Information Units;
MIT, Melodic Intonation Therapy; SAT, Semantic Association Test.
aLevel of education 1 = lowest (primary school), 8 = highest (university); bone
patient was referred to us as aphasic after a large infarct in the left hemisphere. This
patient also participated in an fMRI study we were running. The MRI scan showed a
large infarct in left fronto-parietal regions as well as a right temporo-parietal infarct.
cHandedness before stroke (Edinburgh Handedness Inventory and/or medical
information).
all other outcome measures no significant effect of MIT was
observed. After adjustment for aphasia severity, as expressed by
the score on the AAT Token Test at baseline, outcomes did not
change.
T2–T3
Between T2 and T3 the control group received MIT, whereas
no individual treatment was given to the experimental group
(Figure 1). The graphs in Figure 2 show the mean scores of both
groups for all outcome measures at all test moments.
Visual inspection of these graphs shows a similar pattern after
MIT in the control group (i.e., between T2 and T3) as observed
in the experimental group after MIT (T1–T2): improvement on
the MIT repetition task, both on trained and untrained items
Figures 2E,F), but no improvement on other outcome measures
(Figures 2A–D). In contrast to the experimental group, this
improvement in the control group did not reach significance
(trained items: t = 1.48; p = 0.20; untrained items: t = 2.19;
p = 0.08). There was no difference in MIT intensity in both
groups (experimental group mean MIT (T1–T2) 5.01 h/week
(SD 2.25); control group MIT (T2–T3) 6.04 h/week (SD 0.09);
t = 1.17, p= 0.27).
In the experimental group, the beneficial effect of MIT on
trained items observed at T2 was not maintained at the follow-
up measure 6 weeks later (T3) (Figure 2F). Patients performed
significantly worse on this task at T3 compared to T2 (t =−2.29;
p= 0.049).
Table 3 shows the language improvement after MIT of all
patients (T1, T2 for the experimental group; T2, T3 for the
control group). As a group, patients improve significantly on both
trained and untrained items after MIT.
Responders and Non-responders
Table 4 presents individual data on all outcome measures.
As can be seen in this table, there is a large amount of
individual variation, with some patients showing no language
improvement at all (patients 4, 6, 12, and 14) while others
benefit from MIT. Further, after MIT, repetition of trained
items improved in 8 out of the 16 participating patients, but
generalization to untrained items or functional language only
occurred in a small subset of these patients (for instance patients
2, 7, and 9). No significant differences between responders and
non-responders were observed.
Determinants
Treatment intensity (face-to-face treatment with a speech
language therapist combined with home work assignments) was
the only variable that was significantly related to improvement
on trained items (β = 0.06, p = 0.03). Higher intensity yielded
greater improvement on trained items. None of the other
variables was significantly related to MIT success.
TABLE 2 | Mean scores on all outcome measures (T1 and T2) and group comparisons per outcome measure at T2.
Group comparison
Experimental group (MIT) (n = 10) Control group (no treatment) (n = 7) (MIT versus control)
T1 Mean (SD) T2 Mean (SD) p T1 Mean (SD) T2 Mean (SD) p β p
Sabadel 4.9 (8.9) 5.8 (7.6) 0.50 3.3 (8.3) 5.8 (14.2) 0.18 −1.77 0.50
ANELT 15.7 (6.2) 16.1 (8.3) 0.91 12.9 (7.1) 13.9 (7.2) 0.32 −0.88 0.58
Naming (AAT) 25.7 (27.8) 28.9 (28.3) 0.21 15.4 (34.3) 18.2 (40.7) 0.32 −0.53 0.90
Repetition (AAT) 53.6 (28.5) 59.7 (33.6) 0.12 35.3 (22.7) 43.3 (23.7) 0.046 −3.09 0.61
MIT task: trained items 17.2 (14.5) 30.0 (18.1) <0.01 14.9 (10.4) 14.4 (12.1) 0.75 13.32 0.02
MIT task: untrained items 13.5 (11.7) 18.5 (14.2) 0.03 8.1 (7.2) 10.3 (9.8) 0.17 1.99 0.40
Auditory comprehension (AAT) 40.7 (6.4) 38.5 (10.3) 0.48 40.7 (7.7) 42.3 (9.5) 0.60 −0.05 0.70
SD, standard deviation; ANELT, Amsterdam-Nijmegen Everyday Language Test; AAT, Aachen Aphasia Test. Bold values, significant.
Frontiers in Human Neuroscience | www.frontiersin.org 5 November 2016 | Volume 10 | Article 533
fnhum-10-00533 October 31, 2016 Time: 18:14 # 6
Van Der Meulen et al. Melodic Intonation Therapy in Chronic Aphasia
FIGURE 2 | Mean scores (±1 SD) for all outcome measures at the three test moments. (A) Sabadel; (B) ANELT; (C) Naming (AAT); (D) Repetition (AAT);
(E) MIT repetition, untrained items; (F) MIT repetition, trained items.
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TABLE 3 | Improvement after MIT for all patients (n = 16).
Pre-MIT Post-MIT p
Mean (SD) Mean (SD)
Sabadel 5.6 (11.2) 5.8 (9.3) 0.87
ANELT 15.2 (6.6) 15.6 (8.0) 0.67
Naming (AAT) 25.8 (31.7) 27.3 (30.5) 0.37
Repetition (AAT) 49.6 (27.2) 54.9 (32.3) 0.09
MIT task: trained items 16.8 (13.3) 27.3 (16.7) <0.01
MIT task: untrained items 12.8 (10.8) 18.0 (13.7) <0.01
Auditory comprehension (AAT) 41.1 (7.7) 38.8 (9.4) 0.17
SD, standard deviation; ANELT, Amsterdam-Nijmegen Everyday Language Test;
AAT, Aachen Aphasia Test. Bold values, significant.
DISCUSSION
This is the first RCT examining the efficacy of MIT in the chronic
phase after stroke. We investigated its efficacy at several levels,
and found that, as a group, patients improved on both trained
and untrained items after MIT. When language improvement
after MIT in the experimental group was compared to language
improvement in the untreated control group, MIT appeared to
be only effective on the repetition of trained material, without
generalization effects to untrained material, word retrieval or
verbal communication in daily life. This effect was transient:
6 weeks after finishing MIT, patients had been unable to maintain
their MIT-related language gains.
The study was, however, underpowered and the results
therefore have to be considered as preliminary. The study
might be seen as a pilot RCT and confirmation from larger
RCTs is required to verify our results. This is all the more
important, because our results contrast with findings from
previous studies, in which long term improvement of naming and
verbal communication was reported (Bonakdarpour et al., 2003;
Schlaug et al., 2008, 2009; Hough, 2010; Stahl et al., 2013; Wan
et al., 2014). Also contrary to some studies (Sparks et al., 1974;
Helm-Estabrooks, 1983; Bonakdarpour et al., 2003) we found
no effect of MIT on auditory verbal comprehension. There are
several possible explanations for these differences. First of all, the
lack of generalization effects might be due to the small sample size
and the unequal number of patients in the two groups. We used
the design of a RCT, but because the study was underpowered,
potential positive effects of MIT might have remained unnoticed.
Alternatively, the results of our study, albeit small, suggest that
MIT has only a limited effect in chronic aphasia. The previous
case studies show that individual chronic aphasic patients do
benefit from MIT, but at the group level, its effect is small
and temporary. Note that there is a considerable inter-subject
variation in our study, with some patients obtaining substantial
gains on functional tasks, while others did not benefit at all from
MIT.
This large variation in improvement after MIT raises the
question for which patient MIT is best suited. All participants in
our study fitted the criteria for MIT-candidacy as defined in the
literature (Sparks et al., 1974; Naeser and Helm-Estabrooks, 1985;
Helm-Estabrooks et al., 1989; Sparks, 2008). Nevertheless, within
this well-defined group, patients’ responses to MIT differed. In
order to implement MIT more effectively, stricter criteria are
needed. We were, however, unable to find any patient-related
variables that were significantly related to MIT success. Hence,
the question which patients benefit most from MIT remains open.
The only variable significantly related to improvement after
MIT was treatment intensity. More intensive training yielded
larger improvement on trained items. This is in line with other
studies and reviews showing that higher intensity of aphasia
TABLE 4 | Improvement after MIT (1 post-MIT–pre-MIT) on each outcome measure per patient.
XXXXXXXXPatient nr
Task
Sabadel, CIUs ANELT Naming (AAT) Repetition (AAT) MIT task:
untrained items
MIT task:
trained items
1 1∗ 2 − −8 10 24∗
2 9,5∗ 2 13 21∗ 5 36∗
3 −2 2 9 10 6 16∗
4 0 0 −2 10 3 6
5 3∗ −2 4 17∗ 1 4
6 0 0 4 −5 6 −9
7 −7 1 −6 18∗ 15∗ 11∗
8 0 0 0 6 0 0
9 −6,5 8∗ − 26∗ 11∗ 16∗
10 0 0 2 −4 −2 4
11 0 −2 − −4 9 24∗
12 0 0 0 4 0 0
13 0 0 3 −3 13∗ 15∗
14 0 0 − −13 −1 12∗
15 0 0 0 4 −1 8
16 5∗ −4 −9 5 8 1
∗Significant improvement; −, missing; AAT, Aachen Aphasia Test; ANELT, Amsterdam-Nijmegen Everyday Language Test; CIU, Correct Information Units; MIT, Melodic
Intonation Therapy.
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therapy yields larger language improvement (Robey, 1998; Bhogal
et al., 2003; Bakheit et al., 2007b; Brady et al., 2012). It is possible
that a longer and more intensive treatment would have yielded
generalization to verbal communication. However, not all aphasic
patients are able to engage in an intensive language production
therapy for such a long period of time. The latest Cochrane
review on aphasia therapy showed that studies with high intensity
treatment have a larger number of drop-outs than studies in
which therapy is provided less frequently (Brady et al., 2012).
In our study, there were no drop-outs, suggesting that following
MIT in this intensity is feasible, even in severe non-fluent aphasic
patients.
The optimal timing of aphasia therapy is an important topic in
current aphasia rehabilitation research. Although several studies
point to a larger effect of aphasia therapy if applied in the
first 3 months after stroke, (Robey, 1998; Bakheit et al., 2007a)
a recent review showed that the currently available evidence
on the optimal timing of aphasia therapy is inconclusive and
insufficient (Nouwens et al., 2015). The contradictory findings
may be related to differences in study populations, e.g., including
persons with various types of aphasia and/or receiving different
types of aphasia treatment. Studies examining the efficacy of
one specific treatment at different stages post stroke are rare.
We investigated the effect of MIT in the subacute (Van der
Meulen et al., 2014) and chronic stages post stroke, using
similar study designs and similar outcome measures, allowing
a comparison of the results of both studies. The beneficial
effects of MIT observed in the present study with chronic stroke
patients are less favorable than the effects in the subacute stage
post stroke, where MIT yielded improved repetition of trained
as well as untrained items, with a trend to improved verbal
communication (Van der Meulen et al., 2014). This difference
has to be interpreted cautiously. It may suggest that MIT is
more effective in the subacute stage post stroke. However, our
data do not allow statistical analyses comparing the effect of
MIT in both stages post stroke. Carefully designed studies with
large sample sizes are needed to determine the optimal timing of
MIT.
The small sample size of this study is a clear limitation and
confirmation from larger studies is required. Further, we were
unable to collect data on the size and location of the lesion of
each participant as well as on the severity of their stroke. It has
been suggested that these variables are related to MIT success
(Lazar et al., 2008; Schlaug et al., 2008, 2009; Merrett et al., 2014).
Hence, this information might have led to a better definition of
MIT candidacy.
CONCLUSION
The results of this study suggest that the effect of MIT in
chronic severe non-fluent aphasia is limited. Although the effect
is small and generalization to functional language use could
not be demonstrated, its impact should not be underestimated:
being able to say the name of one’s partner or to ask for a
drink can represent a considerable improvement in the quality
of life of someone who, before MIT, was unable to utter any
intelligible words. At the same time, these results indicate that
the expectations related to MIT in chronic aphasia should not be
raised too high.
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